ARVNArvinas, Inc.

$856M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+146.2% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$4M-104.2% margin

Net Income

-$4M-101.0% margin

EPS (Diluted)

$-3.65

QoQ Revenue Growth

+59.7%

Cash Flow

Operating Cash Flow

$19M

Free Cash Flow

$19M

Stock-Based Comp.

$146,730

Balance Sheet

Total Assets

$116M

Total Liabilities

$65M

Stockholders' Equity

$51M

Cash & Equivalents

$61M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$2M	+146.2%
Gross Profit	$4M	$2M	+146.2%
Operating Income	-$4M	-$6M	+32.2%
Net Income	-$4M	-$6M	+33.5%

ARVN Q1 2018 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena